Details for New Drug Application (NDA): 202220
✉ Email this page to a colleague
NDA 202220 describes PROTRIPTYLINE HYDROCHLORIDE, which is a drug marketed by Epic Pharma Llc, Hikma, and Sigmapharm Labs Llc, and is included in three NDAs. It is available from three suppliers. Additional details are available on the PROTRIPTYLINE HYDROCHLORIDE profile page.
The generic ingredient in PROTRIPTYLINE HYDROCHLORIDE is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
The generic ingredient in PROTRIPTYLINE HYDROCHLORIDE is protriptyline hydrochloride. There are six drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the protriptyline hydrochloride profile page.
Summary for 202220
| Tradename: | PROTRIPTYLINE HYDROCHLORIDE |
| Applicant: | Epic Pharma Llc |
| Ingredient: | protriptyline hydrochloride |
| Patents: | 0 |
Suppliers and Packaging for NDA: 202220
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| PROTRIPTYLINE HYDROCHLORIDE | protriptyline hydrochloride | TABLET;ORAL | 202220 | ANDA | Epic Pharma, LLC | 42806-096 | 42806-096-01 | 100 TABLET, FILM COATED in 1 BOTTLE (42806-096-01) |
| PROTRIPTYLINE HYDROCHLORIDE | protriptyline hydrochloride | TABLET;ORAL | 202220 | ANDA | Epic Pharma, LLC | 42806-096 | 42806-096-10 | 1000 TABLET, FILM COATED in 1 BOTTLE (42806-096-10) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Nov 19, 2012 | TE: | AB | RLD: | No | ||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Nov 19, 2012 | TE: | AB | RLD: | No | ||||
Complete Access Available with Subscription
